Immune Thrombocytopenia (ITP)

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA

Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia

CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia

A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia

A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)

V-IMMUNE® for Immune Thrombocytopenia

A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia

National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients

Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders

An Exploratory Study of Golidocitinib in Adult Patients With ITP

A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)

The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)

Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia